The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis.
 
Steven Brad Maron
Stock and Other Ownership Interests - Calithera Biosciences
Honoraria - Clinical Care Options; MedEd; RMEI Medical Education
Consulting or Advisory Role - Health Advances
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck
 
Walid Khaled Chatila
No Relationships to Disclose
 
Brittanie M Millang
No Relationships to Disclose
 
Shalom Sabwa
No Relationships to Disclose
 
Joanne F. Chou
No Relationships to Disclose
 
Lilan Ling
No Relationships to Disclose
 
Rebecca Nagy
Employment - Guardant Health
 
Marc Simmons
No Relationships to Disclose
 
Richard K. G. Do
Honoraria - ALK (I); Bayer
Consulting or Advisory Role - DBV Technologies (I)
Patents, Royalties, Other Intellectual Property - UptoDate chapters on Food Allergy (I)
 
Viktoriya Paroder
No Relationships to Disclose
 
Hans Gerdes
No Relationships to Disclose
 
Pari M. Shah
No Relationships to Disclose
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Lilly; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck (Inst); Pieris Pharmaceuticals (Inst); Zymeworks
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
David H. Ilson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly/ImClone; Merck; Pieris Pharmaceuticals; Roche/Genentech; Taiho Pharmaceutical
 
Marinela Capanu
No Relationships to Disclose
 
Jaclyn Frances Hechtman
Honoraria - WebMD
Consulting or Advisory Role - Axiom Healthcare Strategies; Cor2Ed
Research Funding - Bayer; Boehringer Ingelheim; Lilly
 
Taha Merghoub
Stock and Other Ownership Interests - Imvaq therapeutics
Honoraria - Leap Therapeutics; Pfizer
Consulting or Advisory Role - Immunos Therapeutics
Research Funding - Bristol-Myers Squibb; Surface Oncology
Patents, Royalties, Other Intellectual Property - inventor on patent applications related to work on oncolytic viral therapy, alphavirus-based vaccines, neo-antigen modeling, CD40, GITR, OX40, PD-1 and CTLA-4.
 
David B. Solit
Stock and Other Ownership Interests - Loxo
Consulting or Advisory Role - Illumina; Intezyne Technologies; Lilly; Loxo; Pfizer; QED Therapeutics; Vividion Therapeutics
Travel, Accommodations, Expenses - Merck KGaA
 
Nikolaus Schultz
No Relationships to Disclose
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo; Jounce Therapeutics; Lilly; Merck; Merck Serono; Michael J. Hennessy Associates; Ono Pharmaceutical; Pfizer; Rgenix
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Genentech; Lilly; Roche